ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$41.93
Tradestie Score
60
Market Cap
$1.17B
Analyst Upside
+78.0%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$21.58
|
$3.31B | - | 52 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$21.47
|
$3.09B | - | 59 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$25.83
|
$3.08B | - | 59 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$36.50
|
$3.02B | - | 56 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$62.54
|
$3.01B | - | 64 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.95
|
$2.89B | - | 40 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$29.10
|
$2.85B | - | 56 | Compare |
More ELVN Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry